What Does HbA1c Tell You About Your Hormones?

What Does HbA1c Tell You About Your Hormones?

HbA1c measures the percentage of hemoglobin coated in glucose over roughly 90 days, giving a longer view of blood sugar than a fasting glucose snapshot. For most people in the normal range (4.8–5.4%), the hormonal impact is modest. The caveat: even a reading in the "prediabetic" grey zone (5.7–6.4%) creates enough glycation stress to measurably blunt thyroid conversion, elevate cortisol output, and suppress estrogen and testosterone. People with hemolytic conditions — sickle cell trait, hemolytic anemia, or recent significant blood loss — may show artificially low HbA1c despite real glycemic stress, because their red blood cells turn over faster and are glycated for less time.

---

Why HbA1c Is a Hormonal Canary, Not Just a Diabetes Marker

Most labs flag HbA1c as abnormal only above 5.7%, but functional medicine practitioners typically aim for 4.8–5.4% — and for good reason. Glucose attaches non-enzymatically to proteins in a process called glycation. When glycation accumulates in tissues, it forms advanced glycation end-products (AGEs) that trigger inflammatory signaling cascades. Those cascades are not neutral to your endocrine system.

The hypothalamic-pituitary-adrenal (HPA) axis is particularly sensitive. Chronic glycemic variability — even within what's labeled "normal" — activates cortisol release as part of a glucose-counterregulatory response. A 2013 study in Psychoneuroendocrinology found that individuals with higher HbA1c had significantly elevated morning cortisol and blunted diurnal cortisol rhythms compared to age-matched controls, independent of body weight (Joseph et al., Psychoneuroendocrinology 2013; PMID: 23623885).

This matters because elevated cortisol doesn't just make you feel wired and tired — it actively inhibits the conversion of thyroxine (T4) to active triiodothyronine (T3), reduces sex hormone-binding globulin (SHBG), and competes with progesterone at the receptor level. The glycation process itself accelerates aging of endocrine tissue: AGEs cross-link proteins in the pituitary gland, potentially dulling the sensitivity of LH and FSH pulses that regulate gonadal hormone production downstream. This means that chronically elevated HbA1c does not just produce a single hormonal disturbance — it degrades the precision of the entire hormonal signaling architecture.

---

HbA1c Optimal vs. Reference Ranges: What the Numbers Actually Mean

Understanding the difference between a "reference range" and an "optimal range" is critical when interpreting your HbA1c alongside hormonal labs.

A 2010 review in The Lancet tracking more than 300,000 participants found that cardiovascular and metabolic risk began rising at HbA1c levels above 5.5%, well before the conventional 6.5% diabetes cutoff (Emerging Risk Factors Collaboration, Lancet 2010; PMID: 20609967). Hormonal disruption follows a similar gradient — it's not a cliff edge at 5.7%, it's a slope that begins earlier.

It is also worth noting that standard HbA1c assays can be misleading in specific populations beyond hemolytic conditions. Individuals with iron deficiency anemia tend to have falsely elevated HbA1c because iron-deficient red cells live longer and accumulate more glycation over their extended lifespan — the opposite artifact from hemolysis. If your HbA1c looks high but your fasting glucose is consistently normal, a ferritin and iron panel is worth running before concluding that glycemic control is truly poor.

---

How Elevated HbA1c Disrupts Thyroid Function

The thyroid connection is one of the most underappreciated links in this chain. T4 to T3 conversion primarily happens in the liver and kidneys via deiodinase enzymes. Elevated insulin resistance — which HbA1c reflects over time — impairs hepatic deiodinase activity, reducing the conversion rate and leaving more reverse T3 (rT3) in circulation.

A 2014 study in Thyroid found that insulin-resistant individuals had significantly higher rT3 and lower Free T3 to rT3 ratios compared to insulin-sensitive controls, even when TSH and Free T4 were within normal range (Ortega et al., Thyroid 2014; PMID: 24073798). If your TSH looks fine but you're exhausted, cold, and gaining weight, your HbA1c may be the piece of the puzzle your doctor isn't connecting.

For context on how thyroid support interacts with broader hormonal panels, see what CRP levels can reveal about your hormone balance — both markers tend to co-vary when metabolic stress is present.

Glycation also directly damages thyroid tissue. AGEs accumulate in the thyroid gland itself, reducing cellular response to TSH and impairing iodine uptake at the follicular cell level. This is a structural problem, not just a signaling one. A useful clinical detail: in individuals with both subclinical hypothyroidism and HbA1c in the 5.7–6.4% range, normalizing blood glucose often produces a measurable improvement in Free T3 without any thyroid-specific intervention — suggesting the glycation burden on deiodinase enzymes is the rate-limiting step, not thyroid gland capacity itself. This has practical implications for how you sequence treatment: addressing HbA1c first may rescue thyroid conversion without the need for additional thyroid hormone support.

---

HbA1c and Sex Hormones: Estrogen, Testosterone, and Progesterone

Elevated HbA1c affects sex hormones through at least three mechanisms:

1. Insulin resistance suppresses SHBG. Sex hormone-binding globulin is produced in the liver, and liver insulin resistance dramatically reduces SHBG output. Lower SHBG means more free estrogen and testosterone initially — but chronic exposure dysregulates receptor sensitivity and accelerates aromatization (conversion of testosterone to estrogen in adipose tissue).

1. Cortisol competes with progesterone. Cortisol and progesterone use the same receptor. When cortisol is chronically elevated — as it is during glycemic dysregulation — it effectively "blocks" progesterone signaling even if serum progesterone looks adequate on a lab panel.

1. Glycation damages Leydig and granulosa cells. These are the primary testosterone-producing cells in men and estrogen/progesterone-producing cells in women. Direct AGE accumulation in gonadal tissue impairs steroidogenesis at the cellular level.

A prospective study published in Diabetes Care found that men with HbA1c above 6.0% had testosterone levels approximately 30% lower than men with HbA1c below 5.5%, after adjusting for age and BMI (Grossmann et al., Diabetes Care 2011; PMID: 21478461). In women, elevated HbA1c is strongly associated with polycystic ovary syndrome (PCOS), a condition defined by hyperandrogenism that is fundamentally driven by insulin resistance.

It is worth flagging the direction of cause and effect here: low testosterone in men independently worsens insulin sensitivity, creating a reinforcing loop where HbA1c elevation suppresses testosterone, and lower testosterone further impairs glucose clearance. Randomized trials of testosterone replacement in hypogonadal men with type 2 diabetes have demonstrated HbA1c reductions of 0.5–1.0 percentage points over 12 months — a meaningful effect that illustrates how tightly these systems are coupled (Hackett et al., J Sex Med 2014; PMID: 24251371).

If you've recently transitioned off hormonal contraception and are trying to understand your baseline hormonal picture, recovering natural hormone balance after coming off the pill is worth reading alongside your HbA1c result — the two are closely linked during the re-establishment of the HPO axis.

---

What Drives HbA1c Up Beyond Obvious Sugar Intake

Many people with elevated HbA1c are surprised because they don't eat a high-sugar diet. The following factors are often overlooked:

• Chronic stress and poor sleep — cortisol elevates fasting glucose via gluconeogenesis, raising HbA1c independent of diet; a single week of sleep restriction to 5 hours/night has been shown to raise fasting insulin by roughly 20% in healthy adults (Spiegel et al., Sleep 2004; NIH reference)
• Nutrient deficiencies — low magnesium impairs insulin receptor sensitivity; low zinc reduces insulin synthesis; low B vitamins impair glucose metabolism at the mitochondrial level
• Thyroid hypofunction — hypothyroidism slows glucose clearance and can elevate HbA1c even with modest carbohydrate intake
• Sedentary behavior — skeletal muscle is the primary glucose sink; reduced muscle mass reduces disposal capacity; resistance training 3x/week has demonstrated HbA1c reductions of 0.3–0.5% in pre-diabetic populations independent of diet change
• Gut dysbiosis — emerging research links SIBO and microbiome imbalances to glucose metabolism disruption via short-chain fatty acid signaling; omega-3 fatty acids and their role in metabolic support are one nutritional lever worth examining here
• Iron deficiency — lower red blood cell lifespan means newer cells are glycated for less time, potentially understating true glycemic burden on standard HbA1c assays
• Certain medications — glucocorticoids, atypical antipsychotics, and some immunosuppressants directly raise fasting glucose and can push HbA1c into the prediabetic range in people whose dietary pattern has not changed

---

Testing Strategy: What to Run Alongside HbA1c

HbA1c alone gives you an average — it hides peaks and valleys that may be more hormonally disruptive than the average suggests. A complete glycemic and hormonal picture typically includes:

Fasting insulin is particularly informative. Research has shown that insulin resistance — measurable by HOMA-IR — exists in a significant proportion of people with HbA1c in the "normal" range (Stern et al., Diabetes Care 2005; NIH reference). This is why some practitioners call normal-range HbA1c with elevated fasting insulin "the invisible metabolic problem." A practical threshold: fasting insulin above 8–10 µIU/mL alongside an HbA1c of 5.3–5.6% is a strong signal to investigate the hormonal downstream effects outlined in this article, even though both values fall within standard reference ranges individually.

For a deeper look at how CoQ10 fits into the broader metabolic and mitochondrial picture, that article covers how energy production efficiency and glycemic metabolism are more closely linked than most standard panels reveal.

---

HbA1c, Adrenal Function, and the Cortisol Feedback Loop

One of the most clinically important but least discussed relationships is between HbA1c and adrenal output. The mechanism runs in both directions:

• Elevated glucose → more cortisol released to "manage" the glucose spike
• More cortisol → more hepatic gluconeogenesis → higher baseline glucose
• Higher baseline glucose → higher HbA1c over 90 days

This bidirectional loop means that adrenal fatigue and glycemic dysregulation are often co-occurring, not independently caused. Treating blood sugar without addressing cortisol rhythm — or vice versa — often yields partial results.

Patients with HPA axis dysfunction frequently present with disrupted glucose variability, and measuring HbA1c alongside a salivary cortisol curve gives a far more complete picture of whether the metabolic problem is dietary or adrenal in origin. Clinically, practitioners using continuous glucose monitors (CGMs) alongside salivary cortisol testing in non-diabetic patients have observed that cortisol spikes from psychological stressors produce measurable glucose excursions of 20–40 mg/dL — excursions that are averaged into HbA1c over 90 days but are entirely invisible to a fasting glucose test taken on a calm morning. This is why an apparently "clean" fasting glucose can coexist with a creeping HbA1c: the stress-glucose signal only shows up when you look across time.

---

What This Means for Your Formula

At Ones, the AI-driven health assessment reviews HbA1c in the context of other biomarkers — fasting insulin, CRP, cortisol patterns from wearable data, and symptom load — before building a personalized capsule formula. The goal isn't to "treat" HbA1c in isolation; it's to address the upstream drivers that the number is pointing to.

Depending on your profile, a Ones formula targeting HbA1c-related hormonal disruption might include:

• Berberine — clinically studied at 1,500 mg/day in divided doses, berberine activates AMPK, improving insulin sensitivity with effect sizes comparable to metformin in some trials (Yin et al., Metabolism 2008; PMID: 18442638). In the Yin trial specifically, 36 adults with newly diagnosed type 2 diabetes saw HbA1c fall from 9.5% to 7.5% over 13 weeks on berberine alone — a 2.0 percentage point reduction that matched the metformin arm. It also reduces hepatic glucose output, directly targeting one mechanism by which cortisol elevates HbA1c.
• Chromium Picolinate — at 200–400 mcg, chromium enhances insulin receptor signaling and has shown modest but consistent HbA1c reductions in randomized controlled trials, particularly in those with baseline deficiency. The effect is most pronounced in people whose chromium status is genuinely depleted — another reason Ones calibrates inclusion to individual lab findings rather than applying a standard stack.
• Magnesium Glycinate — low magnesium is independently associated with insulin resistance. Ones uses a highly bioavailable glycinate form dosed to address deficiency, which matters because magnesium's broader role in metabolic and neurological function is often overlooked in standard glycemic protocols.
• Adrenal Support blend — for users whose wearable and symptom data suggest an HPA axis component to their glycemic pattern, Ones' proprietary Adrenal Support system blend is included to address the cortisol-glucose feedback loop rather than just one side of it. This is particularly relevant when morning cortisol is high-normal and HbA1c is trending upward without a clear dietary cause.

Every formula is calibrated to the individual — a 6-capsule or 9-capsule daily plan based on the breadth of findings the AI identifies, not a fixed template.

---

Key Takeaways

• HbA1c reflects 90-day average glycation, but its impact on hormones starts well before the diabetes threshold — even readings above 5.5% are associated with thyroid conversion impairment and cortisol dysregulation.
• The thyroid connection is structural: AGEs accumulate in thyroid tissue and reduce TSH responsiveness; elevated insulin resistance impairs T4-to-T3 conversion via hepatic deiodinase, and correcting HbA1c can restore Free T3 without thyroid-specific intervention.
• Sex hormones are affected through SHBG suppression, cortisol-progesterone receptor competition, and direct AGE damage to steroidogenic cells — in men, testosterone levels run roughly 30% lower above HbA1c 6.0% vs. below 5.5%.
• The optimal functional range for HbA1c is 4.8–5.4%; the standard "normal" ceiling of 5.6% leaves significant hormonal risk unaddressed.
• HbA1c should never be interpreted alone — fasting insulin, HOMA-IR, Free T3, SHBG, and morning cortisol complete the picture; iron status should also be checked to rule out assay artifacts.
• Addressing elevated HbA1c requires targeting its root causes — which may be adrenal, nutritional, thyroid-related, medication-driven, or dietary — not simply reducing carbohydrate intake.